Page last updated: 2024-08-21

fluorobenzenes and Kidney Failure, Chronic

fluorobenzenes has been researched along with Kidney Failure, Chronic in 23 studies

Research

Studies (23)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	18 (78.26)	29.6817
2010's	5 (21.74)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Azumaya, C; Birmingham, BK; Mitchell, P; Puchalski, T; Swan, SK; Wang, Y; Zalikowski, J	1
Bybee, KA; Lavie, CJ; O'Keefe, JH	1
Nitta, K; Ogawa, T; Sawara, Y; Takei, T; Tsuchiya, K; Uchida, K; Yoshida, T	1
Craig, JC; Strippoli, GF	1
Bannister, K; Beutler, J; Chae, DW; Chevaile, A; Cobbe, SM; De Lima, JJ; Fellström, BC; Gottlow, M; Grönhagen-Riska, C; Holdaas, H; Jardine, AG; Johnsson, E; Lins, R; Mayer, G; McMahon, AW; Parving, HH; Remuzzi, G; Samuelsson, O; Schmieder, RE; Sci, D; Sonkodi, S; Süleymanlar, G; Tesar, V; Todorov, V; Tsakiris, D; Wiecek, A; Wüthrich, RP; Zannad, F	1
Fabbri, G; Maggioni, AP	1
Ganguli, A	1
Ruilope, LM; Segura, J	1
Kassimatis, TI; Konstantinopoulos, PA	1
de Oliveira, JM	1
Athyros, VG; Karagiannis, A; Mikhailidis, DP; Tziomalos, K	1
Aguilar, EA; Ebenezer, PJ; Francis, J; Hu, X; Larroque, M; Lee, BS; Liao, J; Morse, SA; Reisin, E	1
Barrios, V; Escobar, C	1
Bologa, R; Cheigh, J; Gordon, B; Lanto, A; Levine, D; Parker, T; Rubin, A; Stenzel, K	1
Macias, JF; Robles, NR	1
Fellström, BC; Holdaas, H; Holme, I; Jardine, AG; Norby, GE; Schmieder, RE; Zannad, F	1
Abe, M; Ito, M; Maruyama, N; Okada, K; Soma, M; Yoshida, Y	1
Krane, V; Wanner, C	1
Fellström, BC; Holdaas, H; Jardine, AG	1
Davidson, M	1
Gordon, NF; Ranganna, KM; Reddy, RS; Verma, A; Verma, M	1
Deray, G; Isnard-Bagnis, C; Karie, S; Launay-Vacher, V	1
Fellström, B; Holdaas, H; Jardine, AG; Rose, H; Schmieder, R; Wilpshaar, W; Zannad, F	1

Reviews

7 review(s) available for fluorobenzenes and Kidney Failure, Chronic

Article	Year
Cardiovascular risk reduction: what do recent trials with rosuvastatin tell us? Advances in therapy, 2009, Volume: 26, Issue:5 Topics: Cardiovascular Diseases; Cholesterol, HDL; Cholesterol, LDL; Clinical Trials as Topic; Disease Progression; Evidence-Based Medicine; Fluorobenzenes; Heart Failure; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Inflammation; Kidney Failure, Chronic; Practice Guidelines as Topic; Primary Prevention; Pyrimidines; Risk Factors; Risk Reduction Behavior; Rosuvastatin Calcium; Sulfonamides; Treatment Outcome	2009
Statins and cardiovascular events in patients with end-stage renal disease on hemodialysis. The AURORA results suggest the need for earlier intervention. Current vascular pharmacology, 2009, Volume: 7, Issue:3 Topics: Cardiovascular Diseases; Drug Administration Schedule; Fluorobenzenes; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Kidney Failure, Chronic; Pyrimidines; Randomized Controlled Trials as Topic; Renal Dialysis; Rosuvastatin Calcium; Sulfonamides	2009
Rosuvastatin along the cardiovascular continuum: from JUPITER to AURORA. Expert review of cardiovascular therapy, 2009, Volume: 7, Issue:11 Topics: Atherosclerosis; Cardiovascular Diseases; Cholesterol, HDL; Cholesterol, LDL; Clinical Trials as Topic; Fluorobenzenes; Heart Failure; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Kidney Failure, Chronic; Primary Prevention; Pyrimidines; Risk Factors; Rosuvastatin Calcium; Sulfonamides	2009
Cardiovascular risk in uremic patients: darkness after AURORA. Renal failure, 2010, Volume: 32, Issue:2 Topics: Cardiovascular Diseases; Data Interpretation, Statistical; Fluorobenzenes; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Kidney Failure, Chronic; Lipids; Patient Dropouts; Patient Selection; Pyrimidines; Randomized Controlled Trials as Topic; Renal Dialysis; Research Design; Risk; Rosuvastatin Calcium; Sulfonamides; Uremia	2010
Why do we need a statin trial in hemodialysis patients? Kidney international. Supplement, 2003, Issue:84 Topics: Fluorobenzenes; Humans; Hyperlipidemias; Hypolipidemic Agents; Kidney Failure, Chronic; Pyrimidines; Randomized Controlled Trials as Topic; Renal Dialysis; Risk Factors; Rosuvastatin Calcium; Sulfonamides; Uremia	2003
Considerations in the treatment of dyslipidemia associated with chronic kidney failure and renal transplantation. Preventive cardiology, 2005,Fall, Volume: 8, Issue:4 Topics: Atorvastatin; Comorbidity; Dyslipidemias; Fatty Acids, Monounsaturated; Fluorobenzenes; Fluvastatin; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Indoles; Kidney Failure, Chronic; Kidney Transplantation; Lovastatin; Pravastatin; Pyrimidines; Pyrroles; Rosuvastatin Calcium; Simvastatin; Sulfonamides	2005
[Statins in patients with kidney failure: efficacy, tolerance, and prescription guidelines in patients with chronic kidney disease and renal transplant]. Presse medicale (Paris, France : 1983), 2006, Volume: 35, Issue:2 Pt 1 Topics: Adult; Aged; Anticholesteremic Agents; Atorvastatin; Cardiovascular Diseases; Cholesterol; Cholesterol, LDL; Dyslipidemias; Fatty Acids, Monounsaturated; Fluorobenzenes; Fluvastatin; Graft Rejection; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypolipidemic Agents; Indoles; Kidney Failure, Chronic; Liver Transplantation; Middle Aged; Pravastatin; Primary Prevention; Prospective Studies; Proteinuria; Pyrimidines; Pyrroles; Randomized Controlled Trials as Topic; Renal Dialysis; Risk Factors; Rosuvastatin Calcium; Simvastatin; Sulfonamides; Time Factors	2006

Trials

7 trial(s) available for fluorobenzenes and Kidney Failure, Chronic

Article	Year
Effects of lipid-lowering therapy with rosuvastatin on atherosclerotic burden in patients with chronic kidney disease. Internal medicine (Tokyo, Japan), 2008, Volume: 47, Issue:17 Topics: Aged; Atherosclerosis; Cholesterol, LDL; Female; Fluorobenzenes; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Kidney Failure, Chronic; Male; Middle Aged; Prospective Studies; Pyrimidines; Rosuvastatin Calcium; Sulfonamides; Tunica Intima	2008
Rosuvastatin and cardiovascular events in patients undergoing hemodialysis. The New England journal of medicine, 2009, Apr-02, Volume: 360, Issue:14 Topics: Aged; Aged, 80 and over; C-Reactive Protein; Cardiovascular Diseases; Cholesterol; Double-Blind Method; Female; Fluorobenzenes; Follow-Up Studies; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Kaplan-Meier Estimate; Kidney Failure, Chronic; Male; Middle Aged; Prospective Studies; Pyrimidines; Renal Dialysis; Rosuvastatin Calcium; Sulfonamides; Treatment Failure	2009
Pharmacokinetics of rosuvastatin in patients with end-stage kidney disease undergoing peritoneal dialysis. Clinical nephrology, 2009, Volume: 72, Issue:6 Topics: Chromatography, High Pressure Liquid; Dyslipidemias; Female; Fluorobenzenes; Follow-Up Studies; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Kidney Failure, Chronic; Male; Middle Aged; Peritoneal Dialysis, Continuous Ambulatory; Pyrimidines; Rosuvastatin Calcium; Sulfonamides; Treatment Outcome	2009
Rosuvastatin in diabetic hemodialysis patients. Journal of the American Society of Nephrology : JASN, 2011, Volume: 22, Issue:7 Topics: Aged; Aged, 80 and over; C-Reactive Protein; Diabetes Complications; Double-Blind Method; Female; Fluorobenzenes; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Kidney Failure, Chronic; Lipids; Male; Middle Aged; Myocardial Infarction; Pyrimidines; Renal Dialysis; Rosuvastatin Calcium; Sulfonamides	2011
Efficacy analysis of the lipid-lowering and renoprotective effects of rosuvastatin in patients with chronic kidney disease. Endocrine journal, 2011, Volume: 58, Issue:8 Topics: Aged; Blood Glucose; Blood Pressure; Cytoprotection; Diabetic Nephropathies; Female; Fluorobenzenes; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypolipidemic Agents; Kidney; Kidney Failure, Chronic; Male; Middle Aged; Pyrimidines; Rosuvastatin Calcium; Sulfonamides; Treatment Outcome	2011
Effect of rosuvastatin on C-reactive protein and renal function in patients with chronic kidney disease. The American journal of cardiology, 2005, Nov-01, Volume: 96, Issue:9 Topics: Aged; Biomarkers; C-Reactive Protein; Female; Fluorobenzenes; Follow-Up Studies; Glomerular Filtration Rate; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Kidney Failure, Chronic; Lipoproteins, LDL; Male; Prospective Studies; Pyrimidines; Rosuvastatin Calcium; Sulfonamides; Treatment Outcome	2005
Effect of rosuvastatin on outcomes in chronic haemodialysis patients: baseline data from the AURORA study. Kidney & blood pressure research, 2007, Volume: 30, Issue:5 Topics: Aged; Aged, 80 and over; Double-Blind Method; Female; Fluorobenzenes; Humans; Internationality; Kidney Failure, Chronic; Male; Middle Aged; Pyrimidines; Renal Dialysis; Rosuvastatin Calcium; Sulfonamides; Treatment Outcome	2007

Other Studies

9 other study(ies) available for fluorobenzenes and Kidney Failure, Chronic

Article	Year
Pharmacokinetic and pharmacodynamic profile of rosuvastatin in patients with end-stage renal disease on chronic haemodialysis. Clinical drug investigation, 2013, Volume: 33, Issue:4 Topics: Fluorobenzenes; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Kidney Failure, Chronic; Pyrimidines; Renal Dialysis; Rosuvastatin Calcium; Sulfonamides	2013
Intensive lipid intervention in the post-ENHANCE era. Mayo Clinic proceedings, 2008, Volume: 83, Issue:8 Topics: Anticholesteremic Agents; Atorvastatin; Azetidines; Coronary Disease; Diabetes Complications; Disease Progression; Drug Therapy, Combination; Ezetimibe; Fluorobenzenes; Heptanoic Acids; Humans; Hyperlipoproteinemia Type II; Kidney Failure, Chronic; Practice Guidelines as Topic; Pyrimidines; Pyrroles; Randomized Controlled Trials as Topic; Rosuvastatin Calcium; Simvastatin; Sulfonamides	2008
Sunset for statins after AURORA? The New England journal of medicine, 2009, Apr-02, Volume: 360, Issue:14 Topics: Cardiovascular Diseases; Fluorobenzenes; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Kidney Failure, Chronic; Pyrimidines; Renal Dialysis; Rosuvastatin Calcium; Sulfonamides; Treatment Failure	2009
Rosuvastatin in patients undergoing hemodialysis. The New England journal of medicine, 2009, Jul-02, Volume: 361, Issue:1 Topics: Cardiovascular Diseases; Confounding Factors, Epidemiologic; Fluorobenzenes; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperphosphatemia; Hypertrophy, Left Ventricular; Kidney Failure, Chronic; Phosphorus; Pyrimidines; Renal Dialysis; Rosuvastatin Calcium; Sulfonamides	2009
Rosuvastatin, C-reactive protein, LDL cholesterol, and the JUPITER trial. Lancet (London, England), 2009, Jul-04, Volume: 374, Issue:9683 Topics: C-Reactive Protein; Cardiovascular Diseases; Cholesterol, LDL; Fluorobenzenes; Glomerular Filtration Rate; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Kidney Failure, Chronic; Pyrimidines; Research Design; Risk Reduction Behavior; Rosuvastatin Calcium; Sulfonamides; Treatment Outcome	2009
Rosuvastatin in patients undergoing hemodialysis. The New England journal of medicine, 2009, Jul-02, Volume: 361, Issue:1 Topics: Cardiovascular Diseases; Diabetes Complications; Fluorobenzenes; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Kidney Failure, Chronic; Pyrimidines; Renal Dialysis; Risk Factors; Rosuvastatin Calcium; Sulfonamides	2009
Rosuvastatin in patients undergoing hemodialysis. The New England journal of medicine, 2009, Jul-02, Volume: 361, Issue:1 Topics: Age Factors; Cardiovascular Diseases; Fluorobenzenes; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Kidney Failure, Chronic; Pyrimidines; Renal Dialysis; Risk Factors; Rosuvastatin Calcium; Sulfonamides; Treatment Outcome	2009
Effect of the HMG-CoA reductase inhibitor rosuvastatin on early chronic kidney injury in obese zucker rats fed with an atherogenic diet. The American journal of the medical sciences, 2009, Volume: 338, Issue:4 Topics: Animals; Base Sequence; Blood Pressure; C-Reactive Protein; Dietary Fats; DNA Primers; Feeding Behavior; Fluorescent Antibody Technique; Fluorobenzenes; Gene Expression Profiling; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Insulin; Kidney Failure, Chronic; Lipids; Pyrimidines; Rats; Rats, Zucker; Reverse Transcriptase Polymerase Chain Reaction; Rosuvastatin Calcium; Sulfonamides	2009
Sunrise of statins after AURORA and 4D? Journal of the American Society of Nephrology : JASN, 2011, Volume: 22, Issue:7 Topics: Diabetes Complications; Fluorobenzenes; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Kidney Failure, Chronic; Myocardial Infarction; Pyrimidines; Rosuvastatin Calcium; Sulfonamides	2011